About the event
This 45-minute webinar is designed to provide healthcare professionals with the latest information on the risk of Japanese encephalitis for travellers to endemic areas. Presented by Professor Derek Evans; Fellow of the International Society of Travel Medicine and Royal Geographical Society; and Vice-Dean of the Faculty of Travel Medicine.
Send an enquiry
Valneva
Valneva is a global independent vaccine company that covers the full value chain from discovery to commercialisation. Valneva is a fully integrated, commercial stage biotech company focused on developing innovative life-saving vaccines. The Company seeks financial returns through focused R&D investments in promising product candidates and growing financial contributions from commercial products, striving towards financial self-sustainability. Valneva’s portfolio includes two commercial vaccines for travelers: one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by ETEC.
Want to learn more?
Similar CPD Events
Healthcare & Medical
This Week
Japanese encephalitis webinar
Valneva
This 45-minute webinar is designed to provide healthcare professionals with the latest information o...
25 Sep 2024